Immunotec and Nova Southeastern University (NSU) Collaborate on New Autism Study using Immunocal® PR Newswire MONTREAL, July 26, 2011 MONTREAL, July 26, 2011 /PRNewswire/ - Immunotec Inc. (TSXV:...
Important New Research using Immunocal® Shows Promise in Lou Gehrig's Disease PR Newswire MONTREAL, June 14, 2011 MONTREAL, June 14, 2011 /PRNewswire/ - Immunotec Inc. (TSXV: IMM...
NEW YORK, May 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (OTC:IMMP) announced today that the Company expects to begin trading its common stock on the Pink OTC Markets quotation...
NEW YORK, April 21 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that the Company is reorganizing its R&D operations. This restructuring will direct...
NEW YORK, April 3 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Amex: IMM) announced today that it has made an investment in Gold Avenue Ltd., a privately-held Hong Kong company...
NEW YORK, April 2 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE AMEX: IMM) today announced that on March 27, 2009, the Company received notice from the NYSE Amex LLC (the...
NEW YORK, Feb. 27 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has signed a Memorandum of Understanding (MOU) confirming...
NEW YORK, Feb. 13 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM) announced today that the Company will postpone the quarterly update conference call scheduled...
NEW YORK, Jan. 20 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has appointed Virchow, Krause & Company, LLP as its...
NEW YORK, Jan. 16 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (NYSE Alternext US: IMM.BC) today announced that the Company has entered into an agreement to sell Immtech Life Science...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 40 | 0.025 | 0.035 | 0.025 | 3805 | 0.025 | CS |
4 | 0.005 | 16.6666666667 | 0.03 | 0.035 | 0.025 | 12504 | 0.02508886 | CS |
12 | 0.005 | 16.6666666667 | 0.03 | 0.04 | 0.025 | 9192 | 0.02937443 | CS |
26 | -0.025 | -41.6666666667 | 0.06 | 0.07 | 0.025 | 14133 | 0.03773522 | CS |
52 | -0.175 | -83.3333333333 | 0.21 | 0.24 | 0.025 | 24599 | 0.09686907 | CS |
156 | -0.065 | -65 | 0.1 | 0.355 | 0.025 | 23948 | 0.15408524 | CS |
260 | -0.065 | -65 | 0.1 | 0.355 | 0.025 | 23948 | 0.15408524 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約